Growth hormone treatment in growth-retarded adolescents after renal transplant

The Lancet

Volumn 343, Issue 8909, 1994, Pages 1313-1317

  Hokken Koelega, A C S ^a   de Munck Keizer Schrama, S M P F ^a   Drop, S L S ^a   Wolff, E D ^a   Stijnen, T ^b   de Ridder, M A J ^b   de Jong, M C J W ^c   Donckerwolcke, R A ^d   Groothoff, J W ^e   Blum, W F ^f  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GROWTH HORMONE; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; GROWTH RETARDATION; HUMAN; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 0028335531     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)92465-1     Document Type: Article

References (30)

1. Final height and its predictive factors after renal transplantation in childhood
2. Growth in children with chronic renal failure on conservative treatment
3. Growth and endocrine function after renal transplantation
4. Growth and sexual maturation in children after kidney transplantation
5. Levels of growth hormone, IGF-I and -II, IGFBP-1 and -3, and cortisol in prednisone treated children with growth retardation after renal transplantation
6. Placebo-controlled, double-blind cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure
7. Growth stimulating effects of recombinant growth hormone in children with end-stage renal disease
8. Recombinant human growth hormone treatment of children following renal transplantation
9. Safety of growth hormone
10. Growth diagrams 1980. Netherlands third nation-wide biometric survey
11. Longitudinal standards for height, weight, height, weight-velocity and stages of puberty
12. Optimalization of thalamate and hippurate clearance measurements in patients with severe impaired renal function by adjustment of the infusion rate according to prior estimation of GFR and ERPF with the cockroft formula
13. 24-hour plasma GH profiles, urinary GH excretion and plasma IGF-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation
14. Excess of IGF-binding protein in chronic renal failure: evidence for relative GH resistance and inhibition of somatomedin activity
15. Clinical implications of estimation of intact parathyroid (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients
16. Evaluation of a height/ plasmacreatinine formula in the measurement of glomerular filtration rate
17. Prednisone inhibits the efficacy of recombinant human growth hormone in pediatric renal transplant recipients
18. Growth hormone prevents steroid-induced growth depression in health and uremia
19. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulin-like growth factor-1
20. Normal growth of nephrotic children during long-term alternate-day prednisone therapy
21. Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation
22. Alternate-day prednisone treatment may increase kidney transplant rejections
23. Growth hormone resistance and inhibition as somatostatin activity by excess of insulin-like growth factor binding protein in uremia
24. Localisation of the epitope of a monoclonal antibody against human IGFBP-1, functionally interfering with IGF binding
25. Growth after renal transplants
26. Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children
27. Dichotomic action of glucocorticoids on growth hormone secretion
28. Glucocorticoids: Potent inhibitors and stimulators of growth hormone secretion
29. Growth hormone stimulates long bone growth directly